The Biggest Human Experiment Ever
The use of Diethylstilbestrol (DES) has harmed women for decades.
- DES (diethylstilbestrol) experiments in animals were known to cause gynecological anomalies since the 1930s but were ignored by drug and pharmaceutical companies.
- Animals exposed experimentally to DES in utero experienced pregnancy dysfunction due to uterine malformation, metaplasia and dysplasia.
- The presence of early genital abnormalities in the offspring of DES exposed women, including feminization of males and masculinization of females, were ignored by the drug companies.
- DES was used in pregnant women in the 1950s and 1960s without proper testing.
- DES never actually prevented miscarriages.
- DES was never patented, yet was produced by 300 drug companies and was given to mothers in super high doses.
- DES was known to be ineffective since 1954 but was prescribed anyway — the drug companies ignored relevant studies from 1939 to 1949 that cited the dangers of DES.
- DES should never have been put on the market because it never worked and caused irreparable harm to the millions of women and children exposed to it.
- Aaron M. Levine and Associates has been performing diethylstilbestrol associated research since the 1980s and specializes in DES litigation.
The bottom line is that diethylstilbestrol should never have been placed on the market. The drug manufacturers who jumped on the diethylstilbestrol bandwagon either never made the computations or didn't care, but the recommended dosage given to pregnant women was the equivalent of the estrogenic effect of 55,666 birth control pills.
Our Nationwide Attorneys Pursue DES and Breast Cancer Claims
For more information about DES and the dangers that drug and pharmaceutical companies knew existed in their products, contact our Washington, D.C.-based law firm to schedule an appointment. Talk with a lawyer at a free case evaluation and get the honest advice you deserve. Call us toll free at 888-564-9305.
